Operational Syringe Manufacturing Unit – Acquisition Opportunity
1. Location & Market Position: Operational asset with active government supply contracts and high growth potential, located in the UPSIDA Industrial Zone, Lucknow, featuring an established industrial ecosystem and strong logistics connectivity.
2. Infrastructure & Area Details: * Land Area: 3,000 Sq. Yards
- Built-up Area: 18,000 Sq. Ft.
- Configuration: Office Block: 1,000 Sq. Yds (14 ft height RCC) | Production Floor: 2,000 Sq. Yds (14 ft height Shed)
- Power: 500 KV Generator + HT Connection
3. Fixed Asset Valuation (₹30 Cr Total): * Land Value: ₹18 Cr
- Building & Infrastructure: ₹12 Cr
4. Production & Capacity: * Manufacturing: Syringes (2ml–50ml)
- Installed Capacity: 12 Lakh units/day
- Current Production: 3 to 3.5 Lakh units/day
5. Unit Costing & Selling Prices: * Average Production Cost: ₹1.25 per unit (PP @ ₹153/kg)
- Current Selling Prices: 2ml (₹1.40) | 3ml (₹1.45) | 5ml (₹1.65) | 10ml (₹2.75) | 20ml (₹5.50) | 50ml (₹12)
6. Additional Lines & Expansion Opportunity: * Active Line: IV Infusion Set Unit (manual assembly producing 500+ units/labor/day, selling at ₹4/unit).
- Expansion Ready: IV Cannula Line (requires an estimated ₹1.5 to ₹2 Cr investment).
7. Fixed Operational Costs (₹14 Lakhs/Month): * Manpower: ₹9 Lakhs/month
- Electricity & Utilities: ₹5 Lakhs/month
(Note: Excludes raw material costs)
8. Distribution & Client Network: Supplies to Government Medical Colleges, District Hospitals, Private Hospitals, and Diagnostics with an export presence (IndiaMART Verified). Strong distribution network includes GN Associates (Lucknow), Priyanshi Medical (Indo-Nepal belt), and United Surgical (Delhi NCR).
9. Financial Performance & Liabilities: * Last Year Turnover: ₹12 Cr
- Gross Margin: 30% – 35%
- Target Potential: ₹100 Cr/year (post-expansion)
- Existing Liability: ₹7 Cr Bank Loan
10. Total Asking Price: * ₹57 Crore
Yards and Square Feet Real Estate and Strategic Asset Advisory
